← Browse by Condition
Medical Condition
thyroid eye disease ted
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3, Phase 1
ClinicalMetric tracks all active clinical trials for thyroid eye disease ted sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 1
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07211776 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease
Enrollment
99 pts
Location
China
Sponsor
Zai Lab (Shanghai) Co., Ltd.
NCT06569758 Phase 1
Recruiting
A Study of GenSci098 in Subjects With Active Thyroid Eye Disease
Enrollment
76 pts
Location
China
Sponsor
Changchun GeneScience Pharmace...
NCT07400757
Recruiting
Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease
Enrollment
120 pts
Location
Taiwan
Sponsor
Taipei Veterans General Hospit...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology